Janux Revenue and Competitors
Estimated Revenue & Valuation
- Janux's estimated annual revenue is currently $21.2M per year.
- Janux's estimated revenue per employee is $189,598
Employee Data
- Janux has 112 Employees.
- Janux grew their employee count by 37% last year.
Janux's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | VP at Janux Therapeutics | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | Head Human Resources | Reveal Email/Phone |
5 | VP, Accounting | Reveal Email/Phone |
6 | Chief Technical Officer at Janux Therapeutics | Reveal Email/Phone |
7 | Senior Director Regulatory Affairs | Reveal Email/Phone |
8 | Associate Director Program and Portfolio Management | Reveal Email/Phone |
9 | Senior Director, Clinical Science | Reveal Email/Phone |
10 | Chief Business Officer | Reveal Email/Phone |
Janux Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Janux?
N/A
Total Funding
112
Number of Employees
$21.2M
Revenue (est)
37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Janux News
2022-04-20 - Janux Therapeutics (NASDAQ:JANX) Lifted to Hold at Zacks ...
According to Zacks, Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies.
2022-04-17 - Janux Therapeutics (NASDAQ:JANX) Upgraded to Hold by ...
According to Zacks, Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies.
2022-04-13 - Insiders might want to re-evaluate their US$1m stock purchase as Janux
Therapeutics, Inc. (NASDAQ:JANX) drops to US$570m
The Last 12 Months Of Insider Transactions At Janux Therapeutics. The insider Klaus Dorner made the biggest insider purchase in the last 12...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.6M | 112 | 26% | $82.3M |
#2 | $26.8M | 112 | 11% | N/A |
#3 | $15.7M | 112 | 24% | N/A |
#4 | $32.5M | 112 | 17% | N/A |
#5 | $32.5M | 112 | 9% | N/A |